Immuron (IMRN) Cost of Revenue (2016 - 2024)

Immuron (IMRN) recorded quarterly Cost of Revenue of -$874530928.1 billion in Q4 2024, down 112808930498813.45% quarter-over-quarter from $775232.0 in Q4 2023, and down 112808930498813.45% on a YoY basis from N/an in Q1 2024.

Immuron (IMRN) Cost of Revenue (2016 - 2024) Analysis & Trends

Immuron's Cost of Revenue history runs 9 years deep, the most recent figure standing at -$874530928.1 billion for Q4 2024.

  • In Q4 2024, Cost of Revenue fell 112808930498813.45% year-over-year to -$874530928.1 billion; the TTM figure through Dec 2024 stood at -$874530928.1 billion (down 90126392551963.98% YoY), while the FY2025 annual figure was $312370.5, down 69.59% from the prior year.
  • Cost of Revenue was -$874530928.1 billion for Q4 2024 at Immuron, down from $775232.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $775232.0 in Q4 2023 to a low of -$874530928.1 billion in Q4 2024.
  • Historically, Cost of Revenue has averaged -$109316366.0 billion across 5 years, with a median of $19690.2 in 2023.
  • The sharpest annual moves came in 2021 and 2024: Cost of Revenue soared 5568778.93% in 2021, then plunged 112808930498813.45% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $0.01 in 2020, then jumped by 5568778.93% to $508.16 in 2021, then soared by 30545.09% to $155726.0 in 2022, then jumped by 397.82% to $775232.0 in 2023, then slumped by 112808930498813.45% to -$874530928.1 billion in 2024.
  • The last three Cost of Revenue figures came in at -$874530928.1 billion (Q4 2024), $775232.0 (Q4 2023), and $14310.9 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 64.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 48,670.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 392.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 2.05 Mn
10 Immuron 921.61 Mn 921.58 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -874,530,928.08 Bn
Dec 31, 2024 -874,530,928.08 Bn
Dec 31, 2023 775,232.00
Dec 31, 2023 775,232.00
Jun 30, 2023 14,310.93
Jun 30, 2023 14,310.93
Dec 31, 2022 155,726.00
Dec 31, 2022 155,726.00
Jun 30, 2022 25,069.39
Jun 30, 2022 25,069.39
Dec 31, 2021 508.16
Dec 31, 2021 508.16
Dec 31, 2020 0.01
Dec 31, 2020 0.01
Jun 30, 2020 45,879.44
Jun 30, 2020 45,879.44
Dec 31, 2019 4,351.98
Dec 31, 2019 4,351.98
Dec 31, 2018 231,479.00
Dec 31, 2018 231,479.00